In the current study, VPA altered the expression of 11 proteins implicated in Alzheimer’s disease (ATP5A1, ATP5B, ATP5D, ATP5F1, ATP5J, SDHA, SDHB, UQCRB, UQCRC1, UQCRC2, and UQCRH), while 16 proteins implicated in Parkinson’s disease (ATP5A1, ATP5B, ATP5D, ATP5F1, ATP5J, SDHA, SDHB, SLC25A6, UBA7, UQCRB, UQCRC1, UQCRC2, UQCRFS1, UQCRH, VDAC1, and VDAC3). This evidence concerns the gene ATP5F1D and Alzheimer disease.